Teleflex Incorporated (NYSE:TFX) Director Buys $115,860.00 in Stock

Key Points

• Teleflex Incorporated Director Stuart A. Randle purchased 1,000 shares of the company at an average price of $115.86 per share, increasing his position by 15.27%.
• The company reported a quarterly earnings per share of $3.73, exceeding analyst expectations, with revenue reaching $780.90 million, a 4.2% increase year-over-year.
• Teleflex has declared a quarterly dividend of $0.34 per share, representing a 1.2% dividend yield and a dividend payout ratio of 32%.

Teleflex Incorporated (NYSE:TFX - Get Free Report) Director Stuart A. Randle purchased 1,000 shares of Teleflex stock in a transaction dated Tuesday, August 5th. The shares were bought at an average price of $115.86 per share, with a total value of $115,860.00. Following the completion of the transaction, the director owned 7,547 shares in the company, valued at approximately $874,395.42. This trade represents a 15.27% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Teleflex Stock Up 3.0%

Shares of NYSE:TFX traded up $3.35 during midday trading on Thursday, hitting $115.42. 694,762 shares of the stock were exchanged, compared to its average volume of 568,196. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.44 and a current ratio of 2.41. The company has a market capitalization of $5.10 billion, a PE ratio of 27.16, a P/E/G ratio of 1.56 and a beta of 1.08. The business's fifty day simple moving average is $118.16 and its two-hundred day simple moving average is $135.36. Teleflex Incorporated has a 52-week low of $108.90 and a 52-week high of $249.90.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.73 earnings per share for the quarter, topping analysts' consensus estimates of $3.36 by $0.37. The business had revenue of $780.90 million during the quarter, compared to the consensus estimate of $771.53 million. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. Teleflex's revenue for the quarter was up 4.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $3.42 earnings per share. As a group, research analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, September 15th. Investors of record on Friday, August 15th will be given a $0.34 dividend. The ex-dividend date is Friday, August 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.2%. Teleflex's dividend payout ratio (DPR) is presently 32.00%.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on TFX. Truist Financial cut their price target on Teleflex from $140.00 to $137.00 and set a "hold" rating for the company in a research note on Monday, May 5th. Wall Street Zen upgraded shares of Teleflex from a "hold" rating to a "strong-buy" rating in a research report on Saturday, August 2nd. Wells Fargo & Company lowered their price target on shares of Teleflex from $137.00 to $131.00 and set an "equal weight" rating on the stock in a research report on Friday, August 1st. Royal Bank Of Canada boosted their price target on Teleflex from $130.00 to $135.00 and gave the stock a "sector perform" rating in a report on Friday, August 1st. Finally, Morgan Stanley cut their target price on shares of Teleflex from $191.00 to $173.00 and set an "overweight" rating for the company in a research note on Monday, May 5th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $141.57.

Institutional Trading of Teleflex

Several large investors have recently made changes to their positions in TFX. Pzena Investment Management LLC bought a new position in shares of Teleflex in the 2nd quarter valued at $42,149,000. Dimensional Fund Advisors LP increased its stake in shares of Teleflex by 69.5% in the first quarter. Dimensional Fund Advisors LP now owns 867,864 shares of the medical technology company's stock valued at $119,927,000 after buying an additional 355,720 shares during the period. Invesco Ltd. raised its holdings in Teleflex by 48.1% in the 4th quarter. Invesco Ltd. now owns 1,068,593 shares of the medical technology company's stock valued at $190,188,000 after buying an additional 347,003 shares during the last quarter. Diamond Hill Capital Management Inc. increased its position in Teleflex by 122.8% in the 1st quarter. Diamond Hill Capital Management Inc. now owns 584,586 shares of the medical technology company's stock valued at $80,784,000 after acquiring an additional 322,222 shares during the period. Finally, Invenomic Capital Management LP raised its stake in shares of Teleflex by 1,400.1% during the first quarter. Invenomic Capital Management LP now owns 344,732 shares of the medical technology company's stock valued at $47,639,000 after acquiring an additional 321,751 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company's stock.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.